Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology – A Pilot Study

Glioblastoma (GBM) is the most common and aggressive type of tumour arising from the central nervous system. GBM remains an incurable disease despite advancement in therapies, with overall survival of approximately 15 months. Recent literature has highlighted that GBM releases tumoural content which...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller Bark, Juliana, Kulasinghe, Arutha, Hartel, Gunter, Leo, Paul, Warkiani, Majid Ebrahimi, Jeffree, Rosalind L., Chua, Benjamin, Day, Bryan W., Punyadeera, Chamindie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210776/
https://www.ncbi.nlm.nih.gov/pubmed/34150645
http://dx.doi.org/10.3389/fonc.2021.681130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210776/
https://www.ncbi.nlm.nih.gov/pubmed/34150645
http://dx.doi.org/10.3389/fonc.2021.681130

Ejemplares similares